Metraipolis › archive › dc_bc47c7b83ff0
Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH-Bladder Cancer: A Case Report — Europe PMC PMID:42339139
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42339139
- DOI
- 10.1002/ccr3.72855
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T07:16:43.591Z
- SHA-256 of the archived text
13da512cc4c81aded15b49d415d787f6533c2e6c090d5ff0384bbdb0909cd2cd- Stable URL of this page
https://metraipolis.com/documento/dc_bc47c7b83ff0
How to cite
Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH-Bladder Cancer: A Case Report — Europe PMC PMID:42339139 — Europe PMC (en), https://europepmc.org/article/MED/42339139 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bc47c7b83ff0 (Metraipolis archive dc_bc47c7b83ff0, sha256 13da512cc4c81aded15b49d415d787f6533c2e6c090d5ff0384bbdb0909cd2cd)
BibTeX
@misc{dcbc47c7b83ff0,
title = {Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH-Bladder Cancer: A Case Report — Europe PMC PMID:42339139},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42339139},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bc47c7b83ff0; sha256 13da512cc4c81aded15b49d415d787f6533c2e6c090d5ff0384bbdb0909cd2cd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42339139. Agents can read the archived copy with the MCP tool read_document.